|
|
|
Latest News |
| |
Imaging biomarker predicts response to rapid antidepressant
A boost of activity at the back of the brain while processing emotional information predicted depressed patients' responses to an experimental rapid-acting antidepressant. The potential neuroimaging biomarker may eventually help to personalize treatment selection by revealing brain-based differences between patients. Scopolamine can lift depression in many, but not all, patients within a few days. The study found that the more dysfunctional a patient's acetylcholine chemical messenger system, the better they responded to the drug.
View full story
|
| |
| |
| |
|
|
| |
|
|
|
|
|
 |
|
Sign up
Receive our
free newsletter.
View past issues |
| |
Very interesting.
I
especially liked the jungle test in the fun tests.
- Dan Bierenga
|
|
|
All fun and informative tests,
I shared them
with all my friends. Great way to better understand folks.
- Matthew McAvoy |
|
|
|
|
|
|
 |
|
